Laboratorios Farmacéuticos Rovi SA logo

Laboratorios Farmacéuticos Rovi SA (LABFF)

Market Closed
7 Aug, 20:00
OTC PINK OTC PINK
$
67. 17
0
0%
$
4.63B Market Cap
- P/E Ratio
4.37% Div Yield
100 Volume
- Eps
$ 67.17
Previous Close
Add Transaction
Day Range
67.17 90.61
Year Range
67.17 90.61
Want to track LABFF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

LABFF closed Friday higher at $67.17, an increase of 0% from Thursday's close, completing a monthly decrease of -25.8691% or -$23.44. Over the past 12 months, LABFF stock lost -25.8691%.
LABFF pays dividends to its shareholders, with the most recent payment made on Jul 15, 2026. The next estimated payment will be in In 11 months on Jul 15, 2027 for a total of $1.09633.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.7656%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on XMAD (EUR).

LABFF Chart

People also search for

Bangkok Dusit Medical Services Public Company Limited Unsponsored ADR
$ 23.3
0%
Bangkok Dusit Medical Services Public Company Limited
$ 0.56
0%
Makita Corporation Sponsored ADR
$ 34.06
-2.7135%
FNCL 2.5 2013 USB Float
$ 50,000
0%
Alibaba Health Information Technology Ltd.
$ 8.85
0%

Laboratorios Farmacéuticos Rovi SA (LABFF) FAQ

What is the stock price today?

The current price is $67.17.

On which exchange is it traded?

Laboratorios Farmacéuticos Rovi SA is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is LABFF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4.37%.

What is its market cap?

As of today, the market cap is 4.63B.

Has Laboratorios Farmacéuticos Rovi SA ever had a stock split?

No, there has never been a stock split.

Laboratorios Farmacéuticos Rovi SA Profile

Biotechnology Industry
Healthcare Sector
Juan Lopez-Belmonte Encina CEO
OTC PINK Exchange
ES0157261019 ISIN
ES Country
2,197 Employees
13 Jul 2026 Last Dividend
- Last Split
- IPO Date

Overview

Laboratorios Farmaceuticos Rovi, S.A. is a Spanish pharmaceutical company with a global reach, specializing in the research, development, manufacturing, and marketing of pharmaceutical products. Established in 1946 and headquartered in Madrid, Spain, the company operates in various therapeutic areas including cardiology, women's health, anesthesia and pain management, diagnostic imaging, and more. Rovi offers a broad range of products aimed at improving patient healthcare across multiple domains. It also extends its expertise to offer contract-manufacturing services, providing a comprehensive suite of pharmaceutical manufacturing solutions ranging from prefilled syringes to sachets. As a subsidiary of Norbel Inversiones, S.L., Rovi continues to expand its product portfolio and technological capabilities, striving to meet the evolving needs of healthcare professionals and patients worldwide.

Products and Services

  • Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa
  • These are the principal pharmaceutical products offered by Rovi, covering a wide range of medical needs including cardiology, osteoarticular/women's health, anesthesia/pain, central nervous system, urology, endocrinology, respiratory and primary healthcare. Each designed to target specific health conditions, aiding in their treatment and management.

  • Hospital products: Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi
  • Rovi provides a variety of products specifically designed for hospital use, including diagnostic imaging contrast agents and anticoagulants. These products facilitate a range of medical procedures and treatments, supporting healthcare professionals in providing high-quality care.

  • Contract-manufacturing services
  • In addition to its diverse product lineup, Rovi offers contract-manufacturing services to other pharmaceutical companies. This includes the production of a variety of pharmaceutical forms such as prefilled syringes, vials, suppositories, tablets, and sachets. Through these services, Rovi leverages its manufacturing capabilities and expertise to support the wider pharmaceutical industry.

Contact Information

Address: Calle José Isbert, 2
Phone: 34 91 021 30 00